» Articles » PMID: 34886882

A Link Between Mitotic Defects and Mitotic Catastrophe: Detection and Cell Fate

Overview
Journal Biol Direct
Publisher Biomed Central
Specialty Biology
Date 2021 Dec 10
PMID 34886882
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Although the phenomenon of mitotic catastrophe was first described more than 80 years ago, only recently has this term been used to explain a mechanism of cell death linked to delayed mitosis. Several mechanisms have been suggested for mitotic catastrophe development and cell fate. Depending on molecular perturbations, mitotic catastrophe can end in three types of cell death, namely apoptosis, necrosis, or autophagy. Moreover, mitotic catastrophe can be associated with different types of cell aging, the development of which negatively affects tumor elimination and, consequently, reduces the therapeutic effect. The effective triggering of mitotic catastrophe in clinical practice requires induction of DNA damage as well as inhibition of the molecular pathways that regulate cell cycle arrest and DNA repair. Here we discuss various methods to detect mitotic catastrophe, the mechanisms of its development, and the attempts to use this phenomenon in cancer treatment.

Citing Articles

The Co-Administration of Paclitaxel with Novel Pyridine and Benzofuran Derivatives that Inhibit Tubulin Polymerisation: A Promising Anticancer Strategy.

Peruzynska M, Birger R, Klos P, Kwiecien H, Struk L, Sosnicki J Pharmaceutics. 2025; 17(2).

PMID: 40006590 PMC: 11859455. DOI: 10.3390/pharmaceutics17020223.


Advances in non-apoptotic regulated cell death: implications for malignant tumor treatment.

Zhang Y, Yi S, Luan M Front Oncol. 2025; 15:1519119.

PMID: 39949740 PMC: 11821507. DOI: 10.3389/fonc.2025.1519119.


Quinalizarin induces autophagy, apoptosis and mitotic catastrophe in cervical and prostate cancer cells.

Trybus W, Trybus E, Obarzanowski M, Krol T Sci Rep. 2025; 15(1):5252.

PMID: 39939343 PMC: 11822151. DOI: 10.1038/s41598-025-89847-8.


High-throughput screening identifies Aurora kinase B as a critical therapeutic target for Merkel cell carcinoma.

Gelb T, Garman K, Urban D, Coxon A, Gryder B, Hill N Nat Commun. 2025; 16(1):1583.

PMID: 39939315 PMC: 11822212. DOI: 10.1038/s41467-025-56504-7.


Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability.

Bobbitt J, Cuellar-Vite L, Weber-Bonk K, Yancey M, Majmudar P, Keri R J Biol Chem. 2025; 301(2):108196.

PMID: 39826695 PMC: 11849632. DOI: 10.1016/j.jbc.2025.108196.


References
1.
Zamaraev A, Kopeina G, Buchbinder J, Zhivotovsky B, Lavrik I . Caspase-2 is a negative regulator of necroptosis. Int J Biochem Cell Biol. 2018; 102:101-108. DOI: 10.1016/j.biocel.2018.07.006. View

2.
Lescarbeau R, Lei L, Bakken K, Sims P, Sarkaria J, Canoll P . Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma. Mol Cancer Ther. 2016; 15(6):1332-43. PMC: 4893926. DOI: 10.1158/1535-7163.MCT-15-0692. View

3.
Sorokina I, Denisenko T, Imreh G, Tyurin-Kuzmin P, Kaminskyy V, Gogvadze V . Involvement of autophagy in the outcome of mitotic catastrophe. Sci Rep. 2017; 7(1):14571. PMC: 5674033. DOI: 10.1038/s41598-017-14901-z. View

4.
Dominguez-Brauer C, Thu K, Mason J, Blaser H, Bray M, Mak T . Targeting Mitosis in Cancer: Emerging Strategies. Mol Cell. 2015; 60(4):524-36. DOI: 10.1016/j.molcel.2015.11.006. View

5.
Kwok M, Davies N, Agathanggelou A, Smith E, Oldreive C, Petermann E . ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells. Blood. 2015; 127(5):582-95. DOI: 10.1182/blood-2015-05-644872. View